Menarche, the onset of first menstruation in girls, indicates the attainment of reproductive capacity and is a widely used marker of pubertal timing. Age at menarche varies widely between girls and is highly dependent on nutritional status 1 . Early menarche is associated with several adverse health outcomes, including breast cancer 2 , endometrial cancer 3 , obesity 4 , type 2 diabetes 5 and cardiovascular disease 6 , as well as shorter adult stature 4 . Studies of twins and extended families, although largely performed in populations free of nutritional deprivation, estimate that around 50% of the variance in menarche timing is attributable to genetic factors in such settings 7 .
Recently, common variants in LIN28B were associated with age at menarche in four independent genome-wide association studies (GWAS) [8] [9] [10] [11] . LIN28B is a human homolog of lin-28 in Caenorhabditis elegans, which controls the rate of progression from larval stages to adult cuticle formation, indicating the possible conservation of specific micro-RNA regulatory mechanisms involved in developmental timing 9 . A second menarche locus was identified in an intergenic region at 9q31.2 8, 10 . These two loci together explained only 0.6% of the variance in age at menarche 8 . We anticipated that a much larger GWAS would substantially increase the yield of loci associated with age at menarche.
Here we report a much expanded meta-analysis of GWAS for age at menarche. By combining data from the previous studies [8] [9] [10] [11] , plus several further studies to form the ReproGen Consortium, we identified at least 30 previously unidentified loci associated with age at menarche at genome-wide significance levels. Our findings show a close link between the genetic regulation of energy homeostasis and pubertal timing and suggest the presence of other diverse pathways.
RESULTS

Genome-wide association for age at menarche
This expanded GWAS includes data from 32 cohorts of European ancestry (N = 87,802). In most studies, age at menarche was determined by self recall, and the mean age at menarche in individual studies ranged from 12.4 to 13.6 years, excluding individuals with menarche <9 years and >17 years (Online Methods, Supplementary Table 1 and Supplementary Note). Genome-wide SNP genotyping was performed using a variety of different platforms (Supplementary Table 2 and Supplementary Note). Therefore, after applying standard quality control measures, we imputed the genotypes for ~2.5 million autosomal SNPs in the HapMap European CEU sample using Build 35 or 36 to allow inverse variance meta-analysis of additive genetic association results from each study. We also meta-analyzed results from X-chromosome SNPs in studies which had this data available (N = 52,781). Test statistics from each cohort were adjusted using genomic control to avoid inflation of results due to population stratification.
There was strong deviation from the uniform distribution of P values expected under the null hypothesis (Supplementary Fig. 1 ). This deviation was attenuated, but persisted, following removal of those signals associated with the two previously identified loci. In total, 945 SNPs representing 45 loci (r 2 < 0.05 based on HapMap in a 750-kb region) were associated with age at menarche at genome-wide significance levels (P < 5 × 10 −8 ) ( Fig. 1 and Supplementary Fig. 2) . None of these loci were located on the X chromosome. These 45 loci included three apparent second signals (defined as two genome-wide significant SNPs in low linkage disequilibrium (LD) (r 2 < 0.05) in the same 750-kb region) at 2q33.1, 6q21 and 14q32.2. The second signal at 6q21 (rs314279) had a low minor allele frequency (MAF = 6%) and was not present in many studies. We therefore genotyped this SNP de novo in the InCHIANTI cohort and found it was in LD with the top chromosome 6 signal (rs7759938, r 2 = 0.3). In HapMap, the r 2 between the two chromosome 6 SNPs was 0.015, but the D was 1.0. To verify the independence of additional loci, we performed a conditional analysis and a meta-analysis of all 32 studies using the top SNPs at all the 42 genome-wide significant regions as covariates (in addition to birth year). In these conditional analyses, the possible second signals on chromosomes 2 and 14 showed strong but not genome-wide significant associations with age at menarche (P < 7.1 × 10 −6 ), suggestive of, but not confirming, second independent signals in these two regions ( Fig. 1 and Supplementary Table 3 ).
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies A full list of authors and affiliations appear at the end of the paper. 
A r t i c l e s
The two most significant loci for age at menarche confirmed the previously reported associations at LIN28B (rs7759938, P = 1.6 × 10 −58 ) and 9q31.2 (rs2090409, P = 4.4 × 10 −33 ) ( Table 1 and Supplementary Fig. 3 ). In addition, there were genome-wide significant signals for a further 40 possible previously unidentified loci, of which 30 survived a second more stringent correction for the overall genomic control in the stage 1 cohorts (λ = 1.173) ( Table 1 , Fig. 1 and Supplementary Fig. 3 ).
Replication studies
We sought confirmation of the 40 possible new menarche loci in up to 14,731 women from 16 additional studies with in silico GWAS data and new genotyping data from one cohort (Supplementary Tables  4 and 5 ). This replication sample was substantially smaller than our stage 1 sample and was therefore underpowered to confirm individual SNP associations (Supplementary Fig. 4) . Nonetheless, 37 of the 40 possible newly associated loci showed directionally consistent associations in both stages ( Table 1 ; binomial sign test P = 9.7 × 10 −9 ). A combined meta-analysis of the more stringent second genomic control-corrected stage 1 results and replication cohorts gave confirmatory evidence for 30 new menarche loci, leaving 10 unconfirmed possible menarche loci ( Table 1 and Fig. 1) .
Based on the combined stage 1 and replication results, the estimated magnitudes of per-allele effects for the new menarche loci ranged from 4.5 to 2.1 weeks per allele ( Table 1 ) and had an inverse relationship with MAF (Supplementary Fig. 5 ). Among the four largest in silico replication cohorts (each comprising >800 women), the variance in age at menarche explained by all 42 known, confirmed and possible new menarche loci ranged from 3.6% to 6.1% (Supplementary Table 6 ).
Candidate genes at new loci
The strongest new menarche signal was for rs1079866 (3.9 weeks per minor allele; 95% CI 2.9-5.0, P = 5.5 × 10 −14 ) located approximately 250 kb downstream of INHBA, which encodes the protein subunit Inhibin beta A. Heterodimers of Inhibin beta A and the Inhibin alpha subunit form the female reproductive hormone Inhibin A 12 . Inhibin A, produced by granulosa cells in the ovary, increases dramatically during pubertal development in girls 13, 14 and is involved in negative feedback regulation by inhibiting production of follicle stimulating hormone by the pituitary and secretion of gonadotrophin releasing hormone from the hypothalamus 15 . Conversely, homodimers of Inhibin beta A form the hormone Activin A, which stimulates pituitary follicle stimulating hormone production and also exhibits a wide range of biological activities, including the regulation of cellular proliferation and differentiation 16 .
The second strongest new signal was for rs466639 (P = 1.3 × 10 −13 ); this SNP is intronic in RXRG, which encodes retinoid X receptor gamma, a nuclear receptor that forms dimers with the receptors for retinoic acid, thyroid hormone and vitamin D, increasing both DNA binding and transcriptional function on their respective response elements 17 .
Four new loci for menarche were previously identified by GWAS for adult body mass index (BMI) [18] [19] [20] : rs9939609 (in or near FTO, P = 3.1 × 10 −8 ), rs633715 (SEC16B, P = 2.1 × 10 −8 ), rs2002675 (TRA2B and ETV5, P = 1.2 × 10 −9 ) and rs2947411 (TMEM18, P = 1.7 × 10 −8 ). Apart from rs2002675, these menarche signals were either identical to or in tight LD (r 2 > 0.9) with those BMI loci, and in all cases, the BMI-increasing allele was associated with earlier menarche. Variants at these four loci have also been associated with childhood BMI [18] [19] [20] , and these findings support a likely causal effect of childhood BMI on earlier pubertal timing.
Three new menarche loci were found in or near further genes implicated in the regulation of energy homeostasis and body weight in animal models: rs6589964 (P = 1.9 × 10 −12 ) lies ~18 kb from BSX, rs10423674 (P = 5.9 × 10 −9 ) is intronic in CRTC1, and rs4840046 (P = 2.4 × 10 −8 ) lies ~160 kb from MCHR2. BSX encodes a DNAbinding protein and transcriptional activator. In mouse, Bsx is expressed specifically in the pineal gland, telencephalic septum, hypothalamic pre-mammillary body and arcuate nucleus and is necessary for postnatal growth, locomotory behavior, expression of the genes Npy and Agrp, and for the hyperphagic phenotype in leptin deficiency 21 . CRTC1 encodes the CREB-regulated transcription coactivator 1, an activator of cellular gene expression. Crtc1 −/− mice are hyperphagic, obese and infertile, and Crtc1 −/− females have low circulating luteinizing hormone levels 22 . Leptin potentiates the effects of Crtc1 transcriptional activity, and Crtc1 overexpression in hypothalamic cells increases expression of Kisspeptin, which in turn activates secretion of the gonadotrophin releasing hormone. MCHR2 encodes the melanin concentrating hormone receptor 2, an orphan G protein-coupled receptor which shows high affinity binding to the hypothalamic neuropeptide melanin-concentrating hormone (MCH), which regulates nutrient intake and energy homeostasis through MCHR1 23 . Furthermore, MCH directly inhibits gonadotrophin releasing hormone neurons and thereby links energy balance to reproduction 24 .
rs852069 (P = 3.3 × 10 −8 ) lies ~84 kb from PCSK2, which encodes proprotein convertase subtilisin/kexin type 2, an enzyme that cleaves latent precursor proteins, such as proinsulin and proopiomelanocortin, into their biologically active products. Although rare deleterious mutations and common variants in PCSK1 are known to influence obesity risk, it is notable that PCSK2 differs from PCSK1 in that it additionally cleaves pro-luteinizing hormone-releasing hormone and could therefore have a more direct influence on the reproductive hormone axis.
Pathway analyses
Remaining new menarche loci were found in or near genes that are involved in a seemingly diverse range of biological functions (Supplementary Table 7 ). We used ingenuity pathway analysis (IPA) to identify potential biological pathways common to these identified loci. Based on direct interactions only, we identified two functional networks containing 16 and 11 genes, respectively, of those genes nearest to the new menarche loci (Supplementary Fig. 6 ). Network 1, A r t i c l e s related to 'gene expression, cellular growth and proliferation, and cellular function and maintenance' , covers a wide and nonspecific range of biological pathways. Functions in network 2 relate to 'lipid metabolism, small molecule biochemistry and molecular transport' (Supplementary Table 8 ). Central to network 2 are RXRG and several genes involved in fatty acid biosynthesis, including several fatty acid-binding proteins and ACSL1, which encodes an enzyme that converts free long-chain fatty acids into fatty acyl-CoA esters.
To identify potential further biological pathways that influence menarche timing, we used a gene set enrichment analysis (GSEA) UTR, untranslated region.
a Minor allele frequency. b Minor/major allele. c P value for effect heterogeneity between studies. d P value from stage 1 meta-analysis with genomic control applied to individual studies (up to 87,802 women from 32 studies). e P value from stage 1 meta-analysis with additional adjustment for overall genomic control. f P value from in silico replication studies (up to 14,731 women). g Per allele change in age at menarche (weeks) obtained from a meta-analysis of stage 1 and replication cohorts. h Direction of minor allele association with age at menarche in stage 1/replication cohorts. i P value from meta-analysis of stage 1 (second genomic-control-corrected estimates) and replication cohorts. j rs314276 was used as a proxy in the ALSPAC replication sample. k These loci reached genome-wide significance in stage 1 but not in the final analysis with second genomic-control correction and combination with replication cohorts.
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A r t i c l e s approach in meta-analysis gene-set enrichment of variant associations (MAGENTA), in which each gene in the genome is assigned an adjusted score that represents its association with age at menarche, and predefined pathways are tested for enrichment of multiple associations (Online Methods). The most significant pathway (P = 4.9 × 10 −3 ) was the biosynthesis of coenzyme A, which is a carrier of acyl groups and is necessary for pyruvate oxidation and fatty acid synthesis and oxidation (Supplementary Table 9 ).
Functional SNP and structural assessment
We explored the potentially functional impacts of our new menarche loci in order to identify their likely genetic mechanisms. In addition, by particularly focusing on those groups of SNPs that have been identified as functional, we aimed to identify possible further menarche loci which did not reach genome-wide significance in our primary meta-analysis.
Copy number variation.
Using data from a recent genomic map of copy number variation (CNV) 25 , we established that none of the 42 known, confirmed or possible new menarche loci were related to CNVs. Next, we explored the 1,052 CNV-tagging SNPs for association with age at menarche in our GWAS sample. Only one tag SNP was associated with age at menarche after Bonferroni correction (rs3101336, P = 3 × 10 −7 ; Supplementary Fig. 7 ). This SNP tags a CNV near the NEGR1 gene locus, which has been previously associated with body mass index 20 .
Non-synonymous SNPs. None of the 42 known, confirmed or possible new menarche variants were amino acid changing. However, two were in strong LD (r 2 ≥ 0.8) with non-synonymous variants. rs1862471 (intronic in OLFM2 at 19p13.2) is in LD (r 2 = 0.8) with rs2303100, which encodes an arginine to glutamine residue change in OLFM2. Second, rs4929923 (in the 3 untranslated region of TRIM66 at 11p15.4) is in LD (r 2 = 0.92) with rs11042023, which encodes a histidine to arginine residue change in TRIM66.
To identify possible further menarche loci, we then explored the set of 12,062 non-synonymous SNPs for association with age at menarche in our GWAS sample. Outside of the already associated regions, three non-synonymous SNPs were associated with age at menarche after correction for multiple testing (the Bonferroni threshold for 12,062 independent tests was P < 4.1 × 10 −6 ). These non-synonymous SNPs were rs1254319 in C14orf39 (P = 1.9 × 10 −7 ), rs7653652 in C3orf38 (P = 1.4 × 10 −6 ) and rs913588 in JMJD2C (P = 3.3 × 10 −6 ).
Expression QTLs. Three of the forty-two known, confirmed or possible new menarche variants were highly significantly cis associated with mRNA expression (P < 1 × 10 −6 for mRNA transcript abundance) based on publicly available data from lymphoblastoid cell lines of 400 children (mRNA by SNP Browser). These transcripts were in GAB2 (associated with rs10899489), RBM6 (rs6762477) and NARG2 (rs3743266) (Supplementary Table 10 ). As these genomic loci included a number of genes (Supplementary Fig. 3 ), these specific transcript associations inform the likely functional gene at each locus. Given the likely close biological interaction between the regulation of age at menarche and adiposity, we hypothesized that adipose tissue expressed SNPs (eSNPs) might show a preponderance of associations with age at menarche. Of the 5,184 adipose eSNPs identified in the Icelandic Family Adipose cohort 26 , 23 were significantly associated with age at menarche after correction for multiple testing (using a 1/n P value threshold for 5,184 independent tests (P < 1.9 × 10 −4 )) (Supplementary Table 11 ). Of these adipose eSNPs, rs10835211 (menarche P = 9.4 × 10 −6 ) is near BDNF, which is a BMI locus and is implicated in eating behavior and body weight regulation 27, 28 . rs7160413 (menarche P = 2.2 × 10 −5 ) is near DLK1, a gene implicated in early onset puberty 29 . rs133934508 (menarche P = 3.6 × 10 −5 ) is associated with expression of PITX1, which encodes a pituitary transcriptional regulator 30 .
Candidate gene assessment
Candidate gene studies for age at menarche have largely focused on genes involved in sex steroid-hormone biosynthesis and metabolism, highlighted through animal models or human cases with extreme delayed puberty or hypogonadotrophic hypogonadism 31 . We examined 8,770 SNPs in 16 candidate genes [31] [32] [33] and their surrounding regions (±300 kb) for association with age at menarche in our GWAS meta-analysis sample (Supplementary Table 12) . SNPs in the regions of TAC3R (top hit, rs17034046, P = 3.4 × 10 −7 , ~19 kb upstream of TAC3R) and ESR1 (top hit, rs9383922, P = 2.2 × 10 −6 , 110 kb upstream of ESR1) were significantly associated with age at menarche after correction for multiple testing (the Bonferroni threshold for 8,770 independent tests was P < 5.7 × 10 −6 ). Rare deleterious mutations in TAC3R, encoding a receptor for Neurokinin B, and in its ligand TAC3 have been found in families affected by hypogonadotropic hypogonadism and pubertal failure 31 . ESR1 encodes an estrogen receptor that is essential for sexual development and reproductive function, and polymorphisms in ESR1 have previously been nominally associated with age at menarche 33 .
Overlapping heritability of body size and menarche timing
Family studies have suggested a substantial coinheritance of the timing of puberty and BMI 34 , and this is supported by our finding of four established BMI variants among our new menarche loci. We therefore systematically assessed whether established loci for adiposity-related traits (BMI, waist-hip ratio (WHR) and obesity) and adult height were also associated with age at menarche. Nine of the twelve BMI loci and two of the four WHR loci tested were associated with age at menarche ( Table 2 and Supplementary Table 13) . In all cases, the BMI-or WHR-increasing allele was associated with earlier menarche, which is consistent with the direction of association in epidemiological studies 35 . Eleven of the forty-four adult height loci were associated with age at menarche ( Table 3 and Supplementary Table 14) . However, for seven of these loci, the adult height-increasing allele was associated with earlier menarche, which is in the opposite direction to the association in individual-level epidemiological studies 35 .
We then assessed the relevance of our new menarche loci to adult BMI and height by exploring in silico data from the GIANT consortium. Nine of the forty-two menarche loci were associated with adult BMI (at P < 0.05; N = 32,530); in all cases, the allele associated with higher BMI was associated with earlier menarche (Supplementary Table 15) . Eighteen of the menarche loci were associated with adult height (at P < 0.05; N ~ 130,000); although for three of these loci, the direction of effect was opposite to that predicted from epidemiological studies ( Supplementary  Table 16 ). Despite these joint associations with body size, in Avon Longitudinal Study of Parents and Children (ALSPAC) mothers, the combined influence of the menarche loci on age at menarche appeared to be completely unattenuated following adjustment for adult height and BMI (Supplementary Table 17 ), suggesting that in general, these menarche loci have direct effects on age at menarche. However, we acknowledge that further large studies with childhood growth data are needed to establish the causal directions of effect of these loci.
DISCUSSION
In a large GWAS meta-analysis comprising over 87,000 women, we identified 30 new loci for the timing of menarche and provide evidence for a further ten possible new loci. These loci were in or near genes associated with cellular development, body weight regulation, hormonal regulation and a wide variety of other biological functions. Previous studies comprising up to 17,510 women had detected only one or two genome-wide significant signals [8] [9] [10] [11] . We now show that those earlier signals at LIN28B and 9q31.2 represented the 'lowhanging fruit' with particularly large effect sizes relative to their MAF (Supplementary Fig. 5 ). The list of functions of those genes nearest to the menarche loci (Supplementary Table 7 ) and the results of pathway analyses indicate a wide diversity of biological processes that regulate the timing of female pubertal maturation.
Among the confirmed new menarche loci were several loci implicated in body weight regulation, including four loci with established associations with BMI (in or near FTO, SEC16B, TRA2B and TMEM18). Furthermore, our systematic analysis of established BMIrelated SNPs showed that the majority of alleles related to higher BMI and WHR also showed at least nominal associations with earlier menarche ( Table 2) . It is noteworthy that three new menarche loci are in or near genes implicated in energy homeostasis in animal models (BSX, CRTC1 and MCHR2). In the GIANT consortium data, we did not detect any associations between these loci and adult BMI, however the BSX and MCHR2 loci were nominally associated with adult height. In order to robustly investigate whether menarche loci have pleiotropic effects on growth or whether the association with menarche timing is driven through increased adiposity, measures of body fatness before menarche or even before the onset of puberty would be required but were unavailable in most studies. Further functional studies of these new menarche loci may also help to clarify the biological mechanisms linking these traits. In addition to influencing the timing of pubertal initiation, sufficient adiposity is also required for the maintenance of normal hypothalamic-pituitary-gonadal function through signaling by adipocytokines such as leptin 36 . Our pathway analyses highlighted coenzyme A and fatty acid biosynthesis as biological pathways related to menarche timing. Hypothalamic levels of long-chain fatty acyl coenzyme As have been shown to regulate rodent feeding behavior and glucose homeostasis 37 , and genetic variants in this pathway could therefore potentially alter central nutrient sensing.
Earlier age at menarche is related to shorter adult stature in large epidemiological studies 35 . We found that several adult height-increasing alleles were also associated with age at menarche ( Table 3 ), but at different loci, these alleles were associated with either earlier or later menarche. These paradoxical associations suggest a complex interplay between growth and pubertal timing. Earlier menarche is associated with taller, rather than shorter, childhood height, and there are likely separate causal effects of rapid linear growth on earlier puberty and of earlier pubertal maturation on earlier growth plate fusion and cessation of growth.
Although our pathway analyses strongly identified potential new biological pathways involved in pubertal timing, we acknowledge that the ability to assign putative functions to these menarche loci is substantially limited by the lack of identification of the causal variant at each locus. Many of the strongest associated SNPs were located 1 0 8 2 VOLUME 42 | NUMBER 12 | DECEMBER 2010 Nature GeNetics A r t i c l e s hundreds of kilobases distant to the nearest gene, and some menarche loci contained several plausible genes. Indeed, none of the top signals represented non-synonymous SNPs and only two SNPs were in LD with such variants (in OLFM2 and TRIM66). Use of eQTLs helped to identify the likely causal genes (GAB2, RBM6 and NARG2) at three menarche loci that spanned multiple genes. However, much future work will be required to identify the causal variants and implicated genes related to these menarche loci.
Despite the large size of our meta-analysis and the substantial increase in the number of menarche loci, these together explained between 3.6%-6.1% of the variance in age at menarche, equivalent to 7.2%-12.2% of its heritability. The majority of menarche loci had estimated effect sizes of between 2 and 3 weeks per allele. Assuming the presence of many true menarche SNPs with an effect size of 2 weeks per allele, even our large meta-analysis would only have had sufficient power to detect half of those SNPs with a MAF of 50% and only one in ten of those SNPs with MAF of 10% (Supplementary Fig. 8) .
We corrected for population stratification by applying the genomic control method 38 to each of the individual study results. When we applied a more stringent second correction for the overall genomic control inflation factor across all 32 studies, 10 of the 40 possible new menarche variants fell below genome-wide significance ( Fig. 1 and Table 1 ). However, our subsequent finding of confirmatory evidence (P < 0.05) even in our limited replication studies for four of these ten variants (in or near TRIM66, TMEM108, TMEM18 and NFAT5) suggests that the second correction for genomic control is likely to be overconservative.
Our identification of strong associations with SNPs near the candidate genes TAC3R and ESR1 supports the likely presence of further menarche loci which did not meet the genome-wide significance threshold. Systematic assessment of functional genetic variants identified several further putative menarche loci. rs3101336, which tags a CNV near the BMI locus NEGR1, showed strong, but not genomewide significant, association with age at menarche (P = 3 × 10 −7 ). Exploration of adipose tissue eQTLs also identified further putative menarche loci related to genes implicated in eating behavior (BDNF), precocious puberty (DLK1) and pituitary function (PITX1). It has been suggested that lower levels of statistical significance may be applied to variants with prior biological candidacy, however this must be balanced against the desire to avoid false positives, and we suggest that these putative menarche loci require confirmation in further studies.
Notably all of the top menarche variants had MAF ≥ 7%. Although it has been suggested that low-frequency variants have larger effects than common variants 39 , our study was clearly underpowered to detect low-frequency variants (MAF < 5%) with modest effect sizes. It is also possible that rare variants are not well captured using genomewide chips. Future imputation using deep sequencing data from the 1000 Genomes Project may identify additional low frequency hits as well as refine the location of possible functional variants.
In the majority of studies contributing to this report, age at menarche was recalled several years later and often to the nearest completed whole year. Although recalled age at menarche is a valid measure 40 and is unlikely to show systematic bias by genotype, any nondifferential error would lead to reduced statistical power. Menarche indicates the completion of puberty in females, and it is unclear whether our new menarche loci also influence timing of other pubertal phenotypes. The known menarche locus in LIN28B was shown to also influence the onset of breast development in girls, the timing of pubic hair development and voice breaking in boys 9 and the timing of the pubertal growth spurt in both boys and girls 41 . Although our new menarche loci might also regulate such wider pubertal processes, it is plausible that some (for example, INHBA) might have sex-specific effects. Our study was restricted to cohorts of European ancestry and our results are therefore not generalized to other groups. African-American girls tend to show earlier pubertal maturation compared to girls of European ancestry 42 , and genetic studies in such populations might reveal different menarche loci.
In summary, we identified at least 30 new loci for age at menarche. Our findings demonstrate the role of genes which regulate energy homeostasis and hormone pathways and illustrate the complexity of the regulation of the timing of puberty.
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